Phase II Dose-ranging Study of APD421 in PONV

NCT01510704 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

215

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Nausea and Vomiting

Interventions

DRUG: APD421
DRUG: Placebo

Sponsor

Acacia Pharma Ltd